Journal
CELL BIOLOGY INTERNATIONAL
Volume 37, Issue 9, Pages 888-891Publisher
WILEY
DOI: 10.1002/cbin.10111
Keywords
cancer stem cell; cancer therapy; FAK/PI3K/Akt; mechanotransduction
Categories
Funding
- Science and Technology Fund of Sichuan Province [2011SZ0096]
- National Natural Science Foundation of China [30900286, 81030034]
Ask authors/readers for more resources
The cancer stem cell (CSC) concept, which arose about a decade ago, proposes that tumor growth is sustained by a subpopulation of highly malignant cells. These cells, termed CSCs, are capable of extensive self-renewal that contributes to metastasis and treatment resistance. Therefore, therapeutic strategies that target CSCs should be developed for improving outcomes of cancer patients. Recent progress has highlighted the importance of physical properties of the extracellular matrix and mechanotransduction pathway in cancer cells during cancer development. On the other hand, the significance of CXCR1, an upstream signal of FAK/PI3K/Akt has been revealed in CSCs. FAK/PI3K/Akt is a key signal mediator in mechanotransduction pathway. Therefore, mechanotransduction could be a new target for CSCs, and would be an innovative way to treat cancer by inhibiting FAK/PI3K/Akt.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available